stockrowKORU Medical Systems, Inc.
KRMD Healthcare Medical Instruments & Supplies
KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024.
- Revenue
- +18.2%
- EPS
- +222.2%
- Free cash flow
- +26.2%
- Total debt
- −50.9%
Quarter to June 2026, against a year earlier
Follow KRMD
Alert me
KORU Medical Systems, Inc. (KRMD) EV/Sales
As of 5 November 2026, KORU Medical Systems, Inc. (KRMD) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 0.6× (June 2016) to 19.8× (April 2020); the current reading is higher than 29% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.3× | 27.18% |
| FY2024 | 5.0× | 45.34% |
| FY2023 | 3.4× | (33.28%) |
| FY2022 | 5.1× | 11.46% |
| FY2021 | 4.6× | (50.71%) |
| FY2020 | 9.3× | (12.77%) |
| FY2019 | 10.7× | 221.43% |
| FY2018 | 3.3× | 23.09% |
| FY2017 | 2.7× | 171.67% |
| FY2017 | 1.0× | (7.58%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 4.1× | (7.23%) |
| Mar 2026 | 4.4× | (29.82%) |
| Dec 2025 | 6.3× | 46.12% |
| Sep 2025 | 4.3× | 1.07% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OSUR OraSure Technologies, Inc. compare | 0.6× |
| POCI Precision Optics Corp. compare | 1.1× |
| EMBC Embecta Corp. compare | 1.6× |
| PDEX Pro-Dex, Inc. compare | 2.5× |
| SMTI Sanara MedTech Inc. compare | 2.8× |
| KRMD KORU Medical Systems, Inc. | 2.9× |
| STXS Stereotaxis Inc. compare | 3.2× |
| UTMD Utah Medical Products, Inc. compare | 3.9× |
| ZTEKF Zentek Ltd. compare | 259× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)